Manufacturing

While 37 degrees Celsius is the global default for biological research, it may actually induce a state of chronic metabolic sluggishness in chicken muscle cells. The emergence of cellular agriculture marks a pivotal shift in how the world approaches food security and sustainable protein, yet the

The development of a connected nationwide ecosystem for cellular therapy is designed to standardize the quality of regenerative care across every Malaysian state. This ambitious shift is currently reshaping the biotechnology sector, where the focus has moved from being a passive consumer of

Modern industrial sectors are witnessing a quiet revolution where microscopic organisms are replacing heavy machinery and toxic solvents in the race for cleaner and more efficient production. Industrial bioprocessing allows for the creation of complex medicines derived from living organisms,

The inherent inefficiencies of the autologous model are tied to a one-batch-per-patient approach that restricts throughput and maintains high market prices for oncology treatments. While Chimeric Antigen Receptor (CAR) T-cell therapies have redefined oncology by providing life-saving results for

Personalized medicine is emerging as a primary catalyst for manufacturing innovation, requiring flexible platforms that can efficiently produce high-yield therapies for smaller patient populations. This fundamental shift marks the end of the traditional era where massive, stainless-steel vats

Modern pharmaceutical development frequently stalls when chemists deliver a bulk powder that formulation scientists cannot effectively process into a stable dosage form. This persistent challenge is largely a relic of outdated, siloed organizational structures where drug substance synthesis and